HRASLS

HRASLS is a family of proteins that are involved in the metabolism of phospholipids, particularly lysophospholipids. HRASLS proteins can act as phospholipases, catalyzing the hydrolysis of lysophospholipids like LPA and LPC. This hydrolysis plays a crucial role in regulating the levels of these bioactive lipids in the cell. For example, HRASLS3 has phospholipase D activity and can influence the production of signaling molecules derived from lysophospholipids. HRASLS6, on the other hand, has LPCAT activity and can modify the acyl composition of LPC. Dysregulation of HRASLS functions has been associated with various physiological and pathological processes, including inflammation, cancer, and lipid metabolism disorders[1][2].

By Effects: Inhibitor (1)
共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
LEI110

LEI110 是一种有效的、选择性的、可透过细胞的硫醇水解酶 HRASLS 家族泛抑制剂,可抑制 PLA2G16、HRASLS2、RARRES3 和 iNAT(pIC50 值分别为 7.0、6.8、6.8 和 7.6),并在 HepG2 细胞中降低细胞花生四烯酸水平和油酸诱导的脂肪分解。

2313525-90-3
Inhibitor
99.72%
LEI110

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础